Stocks & ETFs to Buy

The No. 1 Stock for This Stagnant Market

Earlier this week, I told you that the market is poised to take a bearish turn and cited three main... Read More

Earlier this week, I told you that the market is poised to take a bearish turn and cited three main reasons:  1. Weak fundamentals 2. Lofty market valuation 3. Investor complacency But I also... Read More

$5 Gold Stock Ready to Resume its Bull Run

The employment report for May was the worst in five years, with the number of jobs created falling... Read More

The employment report for May was the worst in five years, with the number of jobs created falling to just 38,000, well below expectations. Not surprisingly, the U.S. dollar fell sharply, and thanks... Read More

This Sector Just Scored a Dramatic Turnaround

While the real estate sector has been anything but exciting for the past year, it recently... Read More

While the real estate sector has been anything but exciting for the past year, it recently experienced an awakening.  In January, I pointed out a breakdown in iShares US Real Estate (NYSE: IYR)... Read More

Oversold Airline Ready for a Quick Rebound

Trading countertrend moves can be profitable but risky, so it pays to line up as many factors as... Read More

Trading countertrend moves can be profitable but risky, so it pays to line up as many factors as possible in our favor before putting money to work.  When a stock sports a price-to-earnings... Read More

Ignore Your Broker and Buy This Energy Stock

Anyone following the market via their broker’s recommendations would understandably not think very highly of energy stocks. Fortunately, we have charts to follow what the market, not the analysts, has to say. And right now, the charts of numerous oil refiners look to be on the verge of… Read More

My No. 1 Pick in a Sector on the Verge of a Breakout

The biotech sector scored a short-term breakout last week, and the bullishness spread to its larger, more established cousins, the big pharmaceutical stocks.  While most of these drugmakers have been strong of late, they have not broken out on their charts. However, one lagging stock in the group, GlaxoSmithKline (NYSE:… Read More

High-Yielder May be About to Score a Big Rally

With interest rates still in decline, the stodgy, old utilities sector is leading the pack.  Of course, with a more than 20% gain under its belt since early December, it’s unlikely the Dow Jones Utility Average can sustain its recent pace. After all, utilities are not likely to… Read More